1. Home
  2. CRL

as 08-15-2025 4:00pm EST

$
-
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Commercial Physical & Biological Resarch

Nasdaq

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Founded: 1947 Country:
United States
United States
Employees: N/A City: WILMINGTON
Market Cap: 7.3B IPO Year: 2000
Target Price: $186.00 AVG Volume (30 days): 1.1M
Analyst Decision: Buy Number of Analysts: 14
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.37 EPS Growth: N/A
52 Week Low/High: $91.86 - $230.02 Next Earning Date: 08-06-2025
Revenue: $4,028,615,000 Revenue Growth: -1.21%
Revenue Growth (this year): -2.77% Revenue Growth (next year): 2.49%

CRL Daily Stock ML Predictions

Share on Social Networks: